| Product Code: ETC5359028 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The import shipments of buprenorphine to Lithuania in 2024 show a significant shift in concentration, with Germany, Netherlands, and Italy emerging as top exporting countries. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market landscape. Despite a negative growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the past four years has been positive at 1.36%. This data suggests evolving dynamics in the buprenorphine import market in Lithuania, with potential implications for market competitiveness and pricing strategies.

The Buprenorphine market in Lithuania is projected to grow at a stable growth rate of 1.02% by 2027, highlighting the country's increasing focus on advanced technologies within the Europe region, where Germany holds the dominant position, followed closely by United Kingdom, France, Italy and Russia, shaping overall regional demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Lithuania Buprenorphine Market Overview |
3.1 Lithuania Country Macro Economic Indicators |
3.2 Lithuania Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Lithuania Buprenorphine Market - Industry Life Cycle |
3.4 Lithuania Buprenorphine Market - Porter's Five Forces |
3.5 Lithuania Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Lithuania Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Lithuania Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Lithuania Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of buprenorphine therapy in Lithuania |
4.2.2 Rise in the number of individuals seeking treatment for opioid addiction in the country |
4.2.3 Supportive government policies and initiatives to combat opioid abuse |
4.3 Market Restraints |
4.3.1 Stringent regulations and limited accessibility to buprenorphine medication |
4.3.2 Stigma associated with opioid addiction treatment in the society |
5 Lithuania Buprenorphine Market Trends |
6 Lithuania Buprenorphine Market Segmentations |
6.1 Lithuania Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Lithuania Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Lithuania Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Lithuania Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Lithuania Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Lithuania Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Lithuania Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Lithuania Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Lithuania Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Lithuania Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Lithuania Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Lithuania Buprenorphine Market Import-Export Trade Statistics |
7.1 Lithuania Buprenorphine Market Export to Major Countries |
7.2 Lithuania Buprenorphine Market Imports from Major Countries |
8 Lithuania Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in buprenorphine therapy |
8.2 Patient retention rate in buprenorphine treatment programs |
8.3 Number of rehabilitation centers offering buprenorphine-based treatment |
8.4 Rate of successful treatment outcomes in buprenorphine therapy |
8.5 Number of research studies and clinical trials conducted on buprenorphine efficacy and safety in Lithuania |
9 Lithuania Buprenorphine Market - Opportunity Assessment |
9.1 Lithuania Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Lithuania Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Lithuania Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Lithuania Buprenorphine Market - Competitive Landscape |
10.1 Lithuania Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Lithuania Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |